Chest
Volume 133, Issue 5, May 2008, Pages 1071-1074
Journal home page for Chest

Editorials: Point/Counterpoint Editorials
Counterpoint: Evidence-Based Medicine Lacks a Sound Scientific Base

https://doi.org/10.1378/chest.08-0077Get rights and content

Section snippets

Grading

A fundamental premise on which EBM is founded is the ability to grade the quality of research studies. The grading system (levels 1 to 5 evidence) was originally published in a CHEST Supplement (Table 2).2 EBM grading views randomization as not just one important factor but more important than every other component of research methodology. The same concept is rephrased by Sackett et al3: “If the study wasn't randomized, we'd suggest that you stop reading it and go on to the next article.” EBM

Requirements for Reliable Research

Table 3lists eight examples of requirements for reliable research.10 It would be silly to rank these. If one is absent, the research is no longer reliable. Yet, EBM pregrades a study as level 1 evidence if researchers avoided assignment bias (through randomization) even if they ignored the other seven requirements.2 A grading system premised on the belief that randomization can cancel every other methodologic error is contrary to the most elementary understanding of science.

Guidelines

Clinicians have been lured into accepting EBM-based, clinical-practice guidelines in the belief they place medicine on a more scientific basis.12 An example familiar to CHEST readers is the grade A recommendation made by an EBM Task Force for implementation of weaning protocols.13 The task force refers specifically to the study by Ely et al14 as sound evidence. But this study has flawed internal validity: intermittent mandatory ventilation was used in 76% of patients in the control arm, whereas

Harm

You may think EBM does no harm. Not so. Clinical medicine requires thoughtful reflection about each individual patient, whereas graded guidelines encourage reflexive action. A double-blind RCT revealed that spironolactone decreased the mortality rate in patients with severe congestive heart failure (CHF) by 30%.15 The clinical practice guidelines of the American Heart Association subsequently recommended spironolactone for treatment of ventricular dysfunction.16 This was followed by a fourfold

EBM Proves That EBM Is Unsound

The fundamental assumption of EBM is that physicians who practice EBM provide superior care.4 But EBM founders have never undertaken an RCT of the effect of EBM on patient outcome.11 So EBM does not satisfy its own basic requirements, which it demands of everyone else. (Hypocrisy or what?)

They say an RCT of EBM is unnecessary because “outcomes researchers consistently document that patients who receive proven efficacious therapies have better outcomes than those who do not.”20 With this non

What Is the Alternative?

A major attraction of EBM is that it offers a means of coping with uncertainty. Given a physician's responsibility—to make life-and-death decisions about another human—the wish for certainty is understandable, as is the wish of wanting to act like the wisest physician when faced with a problematic patient. But these wishes are contrary to the reality of medicine.

A wise physician makes decisions on a background of scientific theory (universal principles) [Fig 1]. Clinical practice, however,

References (20)

There are more references available in the full text version of this article.

Cited by (55)

  • Why Physiology Is Critical to the Practice of Medicine: A 40-year Personal Perspective

    2019, Clinics in Chest Medicine
    Citation Excerpt :

    What did we get in exchange? The promise that grading of articles (into a hierarchy) would improve patient care, an epistemological strategy that had been demolished by far brighter brains (Karl Popper and critics of the logical-positivism movement) more than 40 years before.92,93 Randomized controlled trials are invaluable in evaluating drugs and other therapies, but provide zero help with the principal impediment in all clinical encounters: perceiving the right diagnosis concealed beneath confounding camouflage (pulmonary embolism).

  • Subarachnoid Hemorrhage

    2018, Handbook of Neuroemergency Clinical Trials: Second Edition
  • Is science the answer?

    2017, British Journal of Anaesthesia
  • Subarachnoid Hemorrhage

    2017, Handbook of Neuroemergency Clinical Trials
  • Subarachnoid hemorrhage international trialists data repository (SAHIT)

    2013, World Neurosurgery
    Citation Excerpt :

    There are many possible reasons for the failure of these trials, including the interventions were ineffective or were administered at the wrong time or dose or to an unresponsive subset of patients, inadequate sample size, insensitive or inappropriate outcome measures, effectiveness of rescue therapies in the placebo group, treatment side effects, intercenter variations in treatment, and practice misalignment (3, 14, 27). Practice misalignment reflects the phenomenon that in critically ill patients, clinicians routinely adjust treatment and care based on multiple factors, which may not occur or be simulated in clinical trials (24). Decades of animal research have led to better understanding of some aspects of the pathogenesis of brain injury of SAH.

View all citing articles on Scopus

Dr. Tobin is Professor of Medicine and Director, Division of Pulmonary and Critical Care Medicine, Loyola University of Chicago Stritch College of Medicine.

The author receives royalties for two books on critical care published by McGraw Hill. The author does not receive financial support for writing, advising, or consulting on evidence-based medicine or grading, or from pharmaceutical, biotechnology, or medical device companies.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).

View full text